HDAC9 and fragile X syndrome: The use of histone deacetylase (HDAC) inhibitors such as sodium valproate and splitomicin has been shown to ameliorate some symptoms in FXS (Tabolacci et al., 2008; Berry-Kravis et al., 2021).